Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rallybio (RLYB) Non Operating Income (2023 - 2025)

Rallybio's Non Operating Income history spans 3 years, with the latest figure at $23.5 million for Q3 2025.

  • For Q3 2025, Non Operating Income rose 1796.85% year-over-year to $23.5 million; the TTM value through Sep 2025 reached $28.8 million, up 568.81%, while the annual FY2024 figure was $5.0 million, 22.61% down from the prior year.
  • Non Operating Income for Q3 2025 was $23.5 million at Rallybio, up from $118000.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $23.5 million in Q3 2025 and bottomed at $62000.0 in Q2 2023.
  • The 3-year median for Non Operating Income is $1.2 million (2024), against an average of $3.2 million.
  • The largest YoY upside for Non Operating Income was 1796.85% in 2025 against a maximum downside of 43.31% in 2025.
  • A 3-year view of Non Operating Income shows it stood at $1.5 million in 2023, then soared by 196.63% to $4.4 million in 2024, then soared by 433.39% to $23.5 million in 2025.
  • Per Business Quant, the three most recent readings for RLYB's Non Operating Income are $23.5 million (Q3 2025), $118000.0 (Q2 2025), and $818000.0 (Q1 2025).